Quarles & Brady 's Simone Colgan Dunlap and Meghan O’Connor offer actionable guidance to help sponsor companies make informed, strategic choices in an evolving AI market.
- Accelerating Clinical Innovation With Open-Source Medical Platforms
- From Supercomputers To The Cloud: How Pharma's R&D Infrastructure Transformation Impacts Clinical Trials
- How To Identify Patient-Centric Risks In The TMF With AI And Automation
- How The TMF Demonstrates Patient Safety And Rights In DCTs
- Begin Your AI-Led Digital Clinical Transformation With A Phased Approach
- How AI Is Rewriting The Future Of TMF And Clinical Quality
- Penetration Testing In Healthcare: Common Vulnerabilities And Programs To Address Them
- Penetration Testing In Healthcare: HIPAA And GDPR Requirements
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
Oncology Preferences From Patients And Caregivers On Trial Tech
Delve into the preferences of patients and caregivers in the field of oncology, specifically regarding eConsent, telehealth, wearables, and other digital technologies.
-
eCOA Evolution: Have We Overcomplicated It?
eCOA has evolved from simple data collection to complex patient engagement platforms, raising concerns about added complexity. Explore innovative tools aimed at simplifying this complexity.
-
The Regulatory Binder Checklist For Clinical Trial Sites
By following this checklist, research teams can enhance organizational efficiency, maintain compliance with regulatory standards, and confidently navigate the complexities of documentation management.
-
Televisits In Clinical Trials: Why Integrate A Telemedicine Feature In Your eCOA Trials?
If remote visits are planned in both decentralized and hybrid trials, how precisely do the televisits work and how beneficial can this really be to study patients, site staff, and sponsors?
-
Supporting Early Phase Oncology Research With The Right Data Management System
Better understand how the evolving landscape drives innovation, why your data capture strategy needs the right technology foundation, and what to look for in a CDMS/EDC system for early-phase oncology.
-
What Are Decentralized Clinical Trials (DCTs)?
Discover how DCTs leverage “virtual” tools, such as telemedicine, sensory-based technologies, wearable medical devices, and direct delivery of study drugs and materials to patients’ homes.
-
Analyzing The FDA's Approach To Diversity In Clinical Trials
Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
-
Immuno-Inflammation Clinical Trials: Challenges And Solutions
Learn why having a strong and robust eCOA solution, along with an understanding of the specific challenges of this therapeutic area, is critical to the success of immuno-inflammation clinical trials.
-
Navigating The eCOA Vendor Landscape In 2025
This guide offers a clear-eyed perspective on the current eCOA landscape, providing sponsors with actionable guidance to make confident, informed vendor choices.
-
Reduce Time, Cost, & Risk With Clinical Study Data Review Software
See how a top 10 global biopharmaceutical company implemented a single data review system to reduce the time, cost, and risk of running its clinical trials while accelerating the time to market.